Infection of a human lymphoblastoid cell line (Jijoye line derived from a Burkitt lymphoma which contains Epstein-Barr virus) with equine herpesvirus 1, maintained and observed for 53 days, was characterized by the continuous production of infectious extracellular and intracellular virus. Maximum virus production correlated with active cell multiplication. Less Herpesviruses, within their group species, characteristically persist in host tissue even in the presence of specific circulating antibody. Bryans (2) showed that viremia in equine herpesvirus 1 (EHV-1)-infected horses persisted as long as 3 weeks and that the virus was associated with an element in the buffy coat layer of blood samples and coexisted with homologous neutralizing antibody.
Herpesviruses, within their group species, characteristically persist in host tissue even in the presence of specific circulating antibody. Bryans (2) showed that viremia in equine herpesvirus 1 (EHV-1)-infected horses persisted as long as 3 weeks and that the virus was associated with an element in the buffy coat layer of blood samples and coexisted with homologous neutralizing antibody.
Several herpesviruses, Epstein-Barr virus (EBV) (5), herpes simplex virus (13) , and herpesvirus macaca (7) replicate and persist in vitro in human lymphoblastoid cell (LO) lines. Data obtained in our study demonstrate the ability of EHV-1 to infect, replicate, and maintain a persistent infection in human LCs.
MATERIALS AND METHODS
Cell cultures. The LC line used was Jijoye (11) , derived from a Burkitt lymphoma and possessing Blymphocyte antigenic characteristics. Jijoye cells are EBV-transformed human peripheral lymphocytes which proliferate indefinitely in vitro. This cell line contains the EBV genome and EBV nuclear antigens and produces demonstrable EB viral capsid antigen (VCA) .
The LC line was grown in RPMI 1640 medium containing 2 mM glutamine, 100 U of penicillin per ml, and 50 mg of streptomycin per ml, with 20% fetal calf serum.
Rabbit kidney-13 (RK-13) cells were used for virus stock production and virus titrations. RK-13 cells for monolayers were propagated in Eagle minimum essential medium, containing 100 U of penicillin per ml and 50 mg of streptomycin per ml, with 10% fetal calf serum, and were maintained in minimum essential medium containing penicillin and streptomycin with 2% fetal calf serum.
Virus. EHV-1 (equine rhinopneumonitis virus), Kentucky-D strain, adapted to RK-13 cells was obtained from J. L. Blue (University of Georgia, Athens, Ga.) and from the American Type Culture Collection. The EHV-1 was passed twice in this laboratory in RK-13 cells; virus stock was prepared from the second passage. When 80% of the monolayer exhibited cytopathic effects, the cells were frozen and thawed three times without removing the culture fluid. The virus suspension was clarified by centrifugation at 8,700 x g for 30 min and concentrated by pelleting at 73,400 x g for 2 h. The virus was titrated in 16-by 125-mm screw-capped tubes containing 5-day-old RK-13 monolayers. The 50% tissue culture infective dose (TCID50) was calculated by the method.
Infected of the LC line. Jijoye cells were sedimented by centrifugation at 200 x g for 10 and washed with phosphate-buffered saline. After the slides dried, 0.05 ml of an equal-part mixture of fluorescein isothiocyanate-conjugated EHV-1 horse antiserum and rhodamine-conjugated goat anti-human immunoglobulin G (Bionetics, Kensington, Md.) was placed in each well, incubated in a moist chamber for 30 min at 37'C, and then washed with phosphatebuffered saline. The slides were dried, and cover slips were mounted. Slides were read for the presence of EB-VCA using the rhodamine system. When a rhodamine fluorescent cell was observed, the filter system was switched to observe if The increase in virus production paralleled with the rapid cell production rate noted between days 7 and 11 and days 21 and 30. After 53 days of continuous growth, the infected LCs still maintained the ability to produce EHV-1.
Direct, indirect, and double-staining FA test. The percentages of EHV-1-infected and uninfected cells with EHV-1-specific fluorescence in the direct FA test are shown in Fig. 1C . About 2,000 cells were examined for each sample. EHV-1-positive LCs showed diffuse specific fluorescence and were enlarged and rounded, contrasting sharply with the negative cells in the same preparation (Fig. 3) . EHV-1-specific fluorescence was not detected until day 7 post-EHV- 1 VOL. 24, 1979 on October 18, 2017 by guest http://iai.asm.org/ Downloaded from were negative. EHV-1 infection had no effect on the expression of EB-VCA as detected with the indirect FA test. In all samples containing control and infected cells, positive EB-VCA was always present in 5% of the cells. In the doublestaining experiment 5% of the Jijoye cells were positive for EB-VCA using rhodamine stain and 15% of the cells were positive for EHV using the fluorescein label. Of those cells positive for EBV, 80% were also positive for EHV. This strongly suggests an association between the production of EHV and EB-VCA in this cell system. The 20% nonassociation between EHV and EB-VCA production may be real or may be due to the limitation of the FA test.
Virus neutralization test. (10) and BJAB (3) cell lines are derived from Burkitt's lymphomas and possess B-lymphocyte antigenic characteristics. The HSB cell line (1) is derived from an acute lymphocytic leukemia and possesses T-lymphocyte characteristics. BJAB and HSB cell lines do not contain detectable EBV genomes, EBV nuclear antigens, or EB-VCAs. The Raji cell line contains EBV genome and EBV nuclear antigen; but unlike the Jijoye cell line, it does not produce demonstrable EB-VCA. These results indicate that neither active EB-VCA production nor EBV genomes were necessary for EHV-1 production.
Attempts to culture infected cells in the presence of specific herpesvirus antiserum resulted in clumping and cell death to antigen-producing cells. When the immune sera were washed off the remaining viable non-FA-positive cells, the culture continued to again produce herpesvirus as detected by FA and isolation tests. This observation, as well as the fact that herpesvirusproducing cells undergo a lytic cycle, strengthens the proposal that the Jijoye-EHV-1 in vitro model represents a latent viral infection with periodic activation.
To date, there is no record of EHV-1 infections of humans. However, as this report shows, EHV-1 has the potential to infect human lymphoblastic cells in vitro. The potential of EHV-1 to be transmitted naturally to humans must be fully assessed. The interaction of EHV-1 and LCs provides a useful in vitro model which may help clarify the mechanism of herpesvirus latency.
